Evidence map›Paper›PMID 36161934›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Highly sensitive single-cell chromatin accessibility assay and transcriptome coassay with METATAC.

Honggui Wu, Xiang Li, Fanchong Jian, Ayijiang Yisimayi, Yinghui Zheng, Longzhi Tan, Dong Xing, X Sunney Xie

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Targeting the 3D genome by anthracyclines for chemotherapeutic effects.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. A machine-readable specification for genomics assays.Bioinformatics (Oxford, England) · 2024
    Article
  7. Article
  8. Highly sensitive single-cell chromatin accessibility assay and transcriptome coassay with METATAC.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Honggui WuBiomedical Pioneering Innovation Center, Peking University, Beijing 100871, China.ORCID 0000-0001-7880-0591
Xiang LiBiomedical Pioneering Innovation Center, Peking University, Beijing 100871, China.ORCID 0000-0001-8842-1595
Fanchong JianBiomedical Pioneering Innovation Center, Peking University, Beijing 100871, China.ORCID 0000-0001-8703-3507
Ayijiang YisimayiBiomedical Pioneering Innovation Center, Peking University, Beijing 100871, China.
Yinghui ZhengBiomedical Pioneering Innovation Center, Peking University, Beijing 100871, China.
Longzhi TanDepartment of Bioengineering, Stanford University, Stanford, CA 94305.ORCID 0000-0002-5618-1299
Dong XingBiomedical Pioneering Innovation Center, Peking University, Beijing 100871, China.ORCID 0000-0002-8237-481X
X Sunney XieBiomedical Pioneering Innovation Center, Peking University, Beijing 100871, China.
Peking University · CNStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in single-cell assay for transposase accessible chromatin using sequencing (scATAC-seq) and its coassays have transformed the field of single-cell epigenomics and transcriptomics. However, the low detection efficiency of current methods has limited our understanding of the true complexity of chromatin accessibility and its relationship with gene expression in single cells. Here, we report a high-sensitivity scATAC-seq method, termed multiplexed end-tagging amplification of transposase accessible chromatin (METATAC), which detects a large number of accessible sites per cell and is compatible with automation. Our high detectability and statistical framework allowed precise linking of enhancers to promoters without merging single cells. We systematically investigated allele-specific accessibility in the mouse cerebral cortex, revealing allele-specific accessibility of promotors of certain imprinted genes but biallelic accessibility of their enhancers. Finally, we combined METATAC with our high-sensitivity single-cell RNA sequencing (scRNA-seq) method, multiple annealing and looping based amplification cycles for digital transcriptomics (MALBAC-DT), to develop a joint ATAC-RNA assay, termed METATAC and MALBAC-DT coassay by sequencing (M2C-seq). M2C-seq achieved significant improvements for both ATAC and RNA compared with previous methods, with consistent performance across cell lines and early mouse embryos.

Indexed as

ChromatinTransposasesAnimalsMiceRNASequence Analysis, DNASingle-Cell AnalysisTranscriptomeChromatinRNATransposasescoaccessibilityimprinted genejoint ATAC–RNAscATAC-seq

Identifiers

PMID36161934
PMCPMC9546615
OpenAlexW4297093998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.